Newsletter Subject

Jeff Brown’s 2021 Prediction Series: A Glut of COVID-19 Vaccines

From

brownstoneresearch.com

Email Address

feedback@e.brownstoneresearch.com

Sent On

Mon, Dec 21, 2020 09:02 PM

Email Preheader Text

Jeff Brown’s 2021 Prediction Series: A Glut of COVID-19 Vaccines Van?s Note: Van Bryan here,

[The Bleeding Edge]( Jeff Brown’s 2021 Prediction Series: A Glut of COVID-19 Vaccines Van’s Note: Van Bryan here, Jeff Brown’s longtime managing editor. In December 2019, Jeff and I sat down to discuss the biggest technology stories of that year and to get his predictions for what 2020 would hold. That series was a hit with readers. So in mid-December, I asked Jeff to sit down again to revisit his predictions and to look forward to the new year. Over the next few days, we’ll be sharing those predictions with readers. Jeff will reveal what he sees coming for 5G networks, biotechnology, and the booming IPO market. He’ll even share what he thinks a Biden administration will mean for the technology market. But for our first issue, we had to start with the story of the year: COVID-19. Read on to see what Jeff Brown sees for the pandemic in the new year and the investment implications it will present. --------------------------------------------------------------- Van Bryan: Jeff, thanks for sitting down to discuss the biggest topics of 2020 and give us some of your predictions for 2021. Jeff Brown: Of course. Happy to do it. Van: We’re going to cover a lot of ground over the next few days. But I think we have to start with COVID-19. When you look back on the year, what stands out to you as it relates to the virus? Jeff: Well, as you know, I had been tracking this virus since the start of the year. Reports of a virus with flu-like symptoms were coming out of Wuhan, China. And I knew almost immediately that this could have far-reaching consequences. After all, I lived through the 2002–2003 SARS epidemic that originated in the Guangdong province of China. At the time, I was living and working in Japan, building a large regional business. I remember traveling to Hong Kong during that time for business. The city was deserted. It was the same with the hotel. It was practically empty. I knew then that I had made a stupid mistake coming to Hong Kong. I stayed one night, never left the hotel, and then returned home. Remember, the mortality rate for SARS was close to 9.5%. In many ways, the world got lucky with COVID-19. It’s not nearly as deadly as SARS. In fact, there’s a growing collection of research that demonstrates it’s no more dangerous than a bad influenza for most people. But when I look back on the year, it’s not the virus itself that stands out to me. It was our reaction to it. Recommended Link [Viral Tech Genius Makes Next Big Prediction]( [image]( Jeff has done it again… [He just got off the Shubert Theater stage — where he shared his No. 1 Tech Stock for 2021…]( And revealed the details behind three valuable new technologies Jeff is certain 99% of the public have never heard of. [Click Here to Watch the Presentation Now]( -- Van: How do you mean? Jeff: A lot of people like to say that COVID-19 was a “black swan” event, something that radically and permanently changes society. I disagree. Coronaviruses are nothing new. Humanity has been dealing with them for literally thousands of years. COVID-19 was not the first. It won’t be the last. But what was unique about this coronavirus was our reaction to it. The real “black swan” event was our reaction to the virus – the global economic lockdowns and new social practices like social distancing and contactless transactions. [The Most Profitable Prediction of Jeff Brown’s Three-Decade Technology Career]( For instance, most people didn’t even notice that digital advertising is now more than 50% of all advertising in the United States. This spike was caused by us spending more time online working or entertaining ourselves. Or look at e-commerce. I shared an insight with readers of The Bleeding Edge back in August. U.S. e-commerce as a percent of retail shot up 36% quarter on quarter and 49% year on year. These are just two examples. We could spend days discussing which technologies have benefited from COVID-19 lockdowns. Food delivery, contactless transactions, autonomous driving technology, cloud-based software, cybersecurity – all these industries are booming right now. And I feel I have to mention that my readers have been profiting from this trend. For instance, we’re up over 340% with DocuSign, over 180% with Square, and about 78% with Amazon in our Near Future Report portfolio. Amazon’s e-commerce and logistics network basically became a public good when the lockdowns hit the U.S. earlier this year. And the dramatic spike in cloud-based applications created even more demand for Amazon Web Services (AWS). Square’s peer-to-peer money transfer application, Cash App, is the simplest and most user-friendly way to conduct contactless transactions. And DocuSign – a company that specializes in online contracts – saw its share price surge as the world socially distanced and conducted more business transactions online. It’s been an incredible year for technology investors, and for readers who have been following my research. Recommended Link [MAJOR Big Bank “Theft” – Is Your Bank on the List?]( [image]( This is outrageous! On page 37 of one of President Trump’s recent financial disclosures… there it was… A stunning line that proved what some consider a “theft” of as much as $4.3 million by one of America’s largest banks. Now, you may not have billions to your name. But here’s what matters… Almost ALL Americans are falling victim to this same “robbery.” In fact, if you have $10,000 in a big bank… Bank of America… Wells Fargo… JPMorgan Chase… Capital One… or others. You’re likely being “taken for a ride” to the tune of almost $1,000 a year… Find out all the details about what’s going on in this video. [Just click here to access it now]( -- Van: It’s been a great year. I looked at The Near Future Report model portfolio earlier. Of the 25 open positions, only one stock is showing a loss, a measly 6%. The remaining 24 recommendations are up triple digits or high double digits. But I have to ask the obvious questions: Can readers expect this sort of performance going forward? Will the adoption of these new technologies slow if a vaccine is approved and the world returns to “normal?” Jeff: I’m glad you brought up the topic of vaccines. That’s my first prediction for 2021. I predict that there will be no fewer than three vaccines approved by the Food and Drug Administration (FDA) by the end of January. You and I are speaking in mid-December. So by the time this publishes, there might already be new developments on this front. [A $49 investment could lead to you making up to 172x on your money]( And I’ll go one step further. Within the calendar year 2021, we can expect anywhere between 500 million to a billion doses of vaccine to be issued around the world. And the vaccine will be prioritized for the most at-risk populations. By mid-2021, I wouldn’t be surprised if there is a glut of COVID-19 vaccines. What this means is that we are months away from this pandemic being effectively over. But the habits that consumers and businesses have formed this year will stay. Consumers have learned how convenient these new technologies are. And enterprises are learning that a remote workforce can be just as effective. In many ways, technology companies have been waiting for a catalyst like this. I like to say they have been “lying in wait.” They needed some major event that would “force” the world to use their products and services. Our response to COVID-19 was that event. Pick almost any technology you want, and you’ll see that the adoption of it has been pulled in by five to ten years. The investment implications of this are enormous. Recommended Link [Why this man just took out $5,345 in one-dollar bills]( [image]( It might be the silliest he’s ever felt in his life… This man just walked out of the bank with $5,345 – all in one-dollar bills. You should’ve seen the teller’s face. But there’s a very good reason. This pile of cash represents the biggest mistake investors are making right now. [In this video, he’ll explain everything… including how to correct this mistake with just three bills from that pile]( [Click here to find out]( -- Van: Let’s talk about that. Where are you going to be focusing your research in 2021? Jeff: We’re going to be targeting several technology trends next year. 5G is getting very “real.” Artificial intelligence is hitting a major inflection point. Self-driving electric cars are also going to have a great year in 2021. [Van’s note: Jeff Brown recently published a new recommendation targeting the booming market of self-driving electric vehicles. Readers of The Near Future Report can read it [here](. And readers who would like to subscribe to gain access to this recommendation can go [right here]( But I’d be remiss if I didn’t mention the incredible opportunities that are forming in the biotechnology space. Consider this. Even with fewer clinical trials – because patients were not comfortable going into medical facilities – the biotechnology space took in record venture capital (VC) funding. Biotechnology also had record levels of initial public offerings (IPOs). The fact that this industry could have its best year in terms of capital formation and IPOs during all this chaos really tells you something. And the incredible vaccine victories we’ve seen in literally just a matter of months has put a spotlight on biotech like never before. This year has been like a shot of adrenaline for the industry. We’re in hyperdrive right now. And it’s not going to stop. I’ve said it before, but I’ll mention it again. The 2020s will be the decade of biotechnology. Fortunes will be made in the years ahead. And my readers can expect to receive research and recommendations on the best biotechnology investments out there. Van: Thanks for your time, Jeff. Jeff: Anytime. --------------------------------------------------------------- Van’s Note: Be sure you tune in tomorrow for our next edition of Jeff Brown’s 2021 prediction series. We’ll discuss how the world will remember COVID-19 and address a few angry emails we received from readers. Catch that in The Bleeding Edge tomorrow. And as Jeff mentioned, biotechnology is on fire right now. For readers who haven’t positioned their portfolio for this massive trend, learn more about Jeff’s No. 1 biotech stock to buy now by [clicking right here](. --------------------------------------------------------------- Like what you’re reading? Send your thoughts to feedback@brownstoneresearch.com. --------------------------------------------------------------- In Case You Missed It... [You only need three stocks – in any market]( While most of the country was in lockdown, Master Trader Jeff Clark went to work. Booking gains of 273%…127%… and 85%… in a matter of days. He’s made gains like this his whole career – using just three stocks. And in his [new Masterclass]( he’ll explain how you can do the same thing. [Check out this preview, where Jeff reveals the names and ticker symbols of all three stocks.]( [image]( --------------------------------------------------------------- Get Instant Access Click to read these free reports and automatically sign up for daily research. [image]( [How to Earn Free Bitcoin]( [image]( [The Ultimate Guide to Taking Back Your Privacy]( [image]( [The Gold Investor’s Guide]( [Brownstone Research]( Brownstone Research 55 NE 5th Avenue, Delray Beach, FL 33483 [www.brownstoneresearch.com]( To ensure our emails continue reaching your inbox, please [add our email address]( to your address book. This editorial email containing advertisements was sent to {EMAIL} because you subscribed to this service. To stop receiving these emails, click [here](. Brownstone Research welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice. To contact Customer Service, call toll free Domestic/International: 1-888-512-0726, Mon–Fri, 9am–7pm ET, or email us [here](mailto:memberservices@brownstoneresearch.com). © 2020 Brownstone Research. All rights reserved. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Brownstone Research. [Privacy Policy]( | [Terms of Use](

EDM Keywords (245)

year world working within whole watch want walked waiting wait virus video van vaccines vaccine use unique tune trend tracking topic took tomorrow time thoughts thinks think theft terms teller technology technologies talk taken surprised sure subscribed subscribe story stop start stands square spotlight spike specializes speaking sort something sitting sit simplest silliest showing shot sharing shared services service series sent seen see say sat sars said robbery ride revisit revealed reveal response research remiss relates redistribution recommendations recommendation received readers read reaction radically questions quarter put pulled publishes public proved profiting products prioritized preview presentation predictions predict positioned portfolio pile percent people peer patients part pandemic outrageous others originated one note next needed nearly names name much months money mistake missed might mention means mean may matter market man making made lying lot loss looked look living lived literally likely like life learning learned last know knew jeff january ipos instance insight industry industries hotel hitting hit habits ground got going glut glad getting get front forming formed food following focusing five first find fewer feel feedback fact face explain expect even entertaining enterprises ensure end effectively effective earlier done docusign discuss details deserted demonstrates demand decade dealing deadly days dangerous cover country could correct coronavirus convenient content consumers consider conducted company coming close click city china caused case buy businesses business brought billions benefited bank ask approved americans america amazon advertising adrenaline adoption address access 85 78 50 340 2021 2020s 2020 180 172x

Marketing emails from brownstoneresearch.com

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

05/12/2024

Sent On

05/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.